KXF [2019] NSWCATGD 40

NSW Civil and Administrative Tribunal New South Wales Medium Neutral Citation: KXF [2019] NSWCATGD 40 Hearing dates: 10 July 2019 Date of orders: 10 July 2019 Decision date: 10 July 2019 Jurisdiction: Guardianship Division Before: J Moir, Senior Member (Legal) Dr B McPhee, Senior Member (Professional) Emeritus Professor P J Foreman, General Member (Community) Decision: The Tribunal consents to the following special medical treatment being provided to KXF: Cyproterone acetate (Androcur) up to a dose of 100 mg twice a day and any necessary treatment that would normally be provided in association with or directly consequent upon the above treatment. This consent is effective for a period of three months from the date of this order. Mrs Z, the appointed guardian for KXF is given the authority to consent to continuation of Cyproterone acetate (Androcur) up to a dose of 100 mg twice a day for the remaining term of the guardianship order. Catchwords: CONSENT TO MEDICAL TREATMENT – application for consent to special medical treatment – subject person with an acquired brain injury – ongoing cognitive impairment – history of disinhibited sexual behaviour – androgen reducing medication for the purpose of behavioural control – Androcur (Cyproterone Acetate) – subject person incapable of providing consent – whether the treatment is the most appropriate form of treatment to promote health and well-being – consent given for a limited period of three months – subject person's appointed guardian given authority to consent to continuation of treatment for the remaining term of the guardianship order. Legislation Cited: Guardianship Act 1987 (NSW), ss 33(2), 42(2), 45(3)(b); Pt 5 Guardianship Regulation 2016 (NSW), reg 14(b) Cases Cited: None cited. Texts Cited: None cited. Category: Principal judgment Parties: 008: Consent to Special Medical Treatment